APYX MEDICAL CORPORATION's ticker is APYX and the CUSIP is 03837C106. A total of 70 filers reported holding APYX MEDICAL CORPORATION in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $823,000 | -56.9% | 126,024 | -15.4% | 0.60% | -46.3% |
| Q4 2021 | $1,909,000 | -34.6% | 148,923 | -29.4% | 1.11% | -39.0% |
| Q3 2021 | $2,921,000 | +43.4% | 210,869 | +6.7% | 1.82% | +71.7% |
| Q2 2021 | $2,037,000 | +19.4% | 197,577 | +11.9% | 1.06% | +15.7% |
| Q1 2021 | $1,706,000 | +42.3% | 176,587 | +6.0% | 0.92% | +10.2% |
| Q4 2020 | $1,199,000 | +372.0% | 166,536 | +208.7% | 0.83% | +306.8% |
| Q3 2020 | $254,000 | +19.2% | 53,942 | -9.1% | 0.20% | -36.3% |
| Q1 2020 | $213,000 | -91.8% | 59,364 | -80.8% | 0.32% | -88.7% |
| Q4 2019 | $2,613,000 | +35.4% | 308,863 | +8.4% | 2.84% | +25.6% |
| Q3 2019 | $1,930,000 | -4.3% | 285,013 | -5.0% | 2.26% | +8.5% |
| Q2 2019 | $2,016,000 | -29.8% | 300,013 | -34.1% | 2.08% | -14.0% |
| Q1 2019 | $2,873,000 | – | 455,313 | – | 2.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invenire Partners, LP | 410,999 | $2,683,823,000 | 3.37% |
| Archon Capital Management LLC | 2,333,589 | $15,238,000 | 1.88% |
| COWEN AND COMPANY, LLC | 2,634,003 | $17,200,000 | 1.66% |
| Taylor Frigon Capital Management LLC | 510,094 | $3,331,000 | 1.24% |
| Cowen Prime Advisors LLC | 253,859 | $1,658,000 | 0.70% |
| Millrace Asset Group, Inc. | 126,024 | $823,000 | 0.60% |
| Kent Lake Capital LLC | 134,994 | $882,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,398,279 | $22,191,000 | 0.46% |
| GREENWOOD CAPITAL ASSOCIATES LLC | 144,293 | $942,000 | 0.25% |
| PURA VIDA INVESTMENTS, LLC | 982,683 | $6,417,000 | 0.21% |